C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation

Oncogene

Volumn 24, Issue 9, 2005, Pages 1589-1597

  Gery, Sigal ^a,c   Tanosaki, Sakae ^a   Hofmann, Wolf K ^b   Koppel, Ahrin ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

BCR ABL; C EBP ; Granulocytic differentiation

Indexed keywords

BCR ABL PROTEIN; CCAAT ENHANCER BINDING PROTEIN; CD34 ANTIGEN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; MYC PROTEIN; PROTEIN P27; RNA; ZINC; CCAAT ENHANCER BINDING PROTEIN DELTA; CEBPD PROTEIN, HUMAN; GROWTH PROMOTOR; TRANSCRIPTION FACTOR;

ARTICLE; BONE MARROW CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GRANULOCYTE; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ONCOGENE C MYC; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL DIVISION; DRUG EFFECT; GENETICS; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 14944358752     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208393     Document Type: Article

References (38)

1. Ahuja H, Bar-Eli M, Arlin Z, Advani S, Allen SL, Goldman J, Snyder D, Foti A and Cline M. (1991). J. Clin. Invest., 87, 2042-2047.
2. Asimakopoulos FA, Shteper PJ, Krichevsky S, Fibach E, Polliack A, Rachmilewitz E, Ben-Neriah Y and Ben-Yehuda D. (1999). Blood, 94, 2452-2460.
3. Billiard J, Umayahara Y, Wiren K, Centrella M, McCarthy TL and Rotwein P. (2001). J. Biol. Chem., 276, 15354-15361.
4. Breed DR, Margraf LR, Alcorn JL and Mendelson CR. (1997). Endocrinology, 138, 5527-5534.
5. Cantwell CA, Sterneck E and Johnson PF. (1998). Mol. Cell. Biol., 18, 2108-2117.
6. Cao Z, Umek RM and McKnight SL. (1991). Genes Dev., 5, 1538-1552.
7. Chen PL, Riley DJ, Chen Y and Lee WH. (1996). Genes Dev., 10, 2794-2804.
8. D'Alo' F, Johansen LM, Nelson EA, Radomska HS, Evans EK, Zhang P, Nerlov C and Tenen DG. (2003). Blood, 102, 3163-3171.
9. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K and Oberg F. (2002). Blood, 99, 2199-2206.
10. Duprez E, Wagner K, Koch H and Tenen DG. (2003). EMBO J., 22, 5806-5816.
11. Friedman AD. (2002). Oncogene, 21, 3377-3390.
12. Gery S, Gombart AF, Fung YK and Koeffler HP. (2004). Blood, 103, 828-835.
13. Gheorghiu I, Deschenes C, Blais M, Boudreau F, Rivard N and Asselin C. (2001). J. Biol. Chem., 276, 44331-44337.
14. Hoffman B, Amanullah A, Shafarenko M and Liebermann DA. (2002). Oncogene, 21, 3414-3421.
15. Hofmann WK, de Vos S, Komor M, Hoelzer D, Wachsman W and Koeffler HP. (2002). Blood, 100, 3553-3560.
16. Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa S, Ishikawa T, Yazaki Y and Hirai H. (2000). Blood, 95, 1144-1150.
17. Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR and Tenen DG. (2001). Mol Cell Biol., 21, 3789-3806.
18. Jones LC, Lin ML, Chen SS, Krug U, Hofmann WK, Lee S, Lee YH and Koeffler HP. (2002). Blood, 99, 2032-2036.
19. Kubota T, Hirama T, Verbeek W, Kawano S, Chih DY, Chumakov AM, Taguchi H and Koeffler HP. (2001). Leuk. Res., 25, 981-995.
20. Mori N, Morosetti R, Lee S, Spira S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H and Koeffler HP. (1997). Blood, 90, 2010-2014.
21. Morosetti R, Park DJ, Chumakov AM, Grillier I, Shiohara M, Gombart AF, Nakamaki T, Weinberg K and Koeffler HP. (1997). Blood, 90, 2591-2600.
22. O'Rourke JP, Newbound GC, Hutt JA and DeWille J. (1999). J. Biol. Chem., 274, 16582-16589.
23. Park DJ, Chumakov AM, Vuong PT, Chih DY, Gombart AF, Miller Jr WH and Koeffler HP. (1999). J. Clin. Invest., 103, 1399-1408.
24. Perez-Roger I, Solomon DL, Sewing A and Land H. (1997). Oncogene, 14, 2373-2381.
25. Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA and Calabretta B. (2002). Nat. Genet., 30, 48-58.
26. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT and Tenen DG. (1998). Mol. Cell. Biol., 18, 4301-4314.
27. Ramji DP and Foka P. (2002). Biochem. J., 365, 561-575.
28. Schuster C, Forster K, Dierks H, Elsasser A, Behre G, Simon N, Danhauser-Riedl S, Hallek M and Warmuth M. (2003). Blood, 101, 655-663.
29. Scott LM, Civin CI, Rorth P and Friedman AD. (1992). Blood, 80, 1725-1735.
30. Slomiany BA, D'Arigo KL, Kelly MM and Kurtz DT. (2000). Mol. Cell. Biol., 20, 5986-5997.
31. Tanaka T, Yoshida N, Kishimoto T and Akira S. (1997). EMBO J., 16, 7432-7443.
32. Tavor S, Park DJ, Gery S, Vuong PT, Gombart AF and Koeffler PH. (2003). J. Biol. Chem., 278, 52651-52659.
33. Timchenko NA, Wilde M and Darlington GJ. (1999). Mol. Cell. Biol., 19, 2936-2945.
34. Vegesna V, Takeuchi S, Hofmann WK, Ikezoe T, Tavor S, Krug U, Fermin AC, Heaney A, Miller CW and Koeffler HP. (2002). Leuk. Res., 26, 451-457.
35. Verbeek W, Gombart AF, Chumakov AM, Muller C, Friedman AD and Koeffler HP. (1999). Blood, 93, 3327-3337.
36. Wang QF and Friedman AD. (2002). Blood, 99, 2776-2785.
37. Yamanaka R, Lekstrom-Himes J, Barlow C, Wynshaw-Boris A and Xanthopoulos KG. (1998). Int. J. Mol. Med., 1, 213-221.
38. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP and Sonenshein GE. (2001). Oncogene, 20, 1688-1702.